Evelo Biosciences Inc EVLO:OTCPK

RT Quote | Exchange | USD
Last | 06/29/23 EDT
0.1765UNCH (UNCH)
Volume
11,655,027
52 week range
0.02 - 3.29
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.1765
  • 52 Week High3.29
  • 52 Week High Date08/11/22
  • 52 Week Low0.02
  • 52 Week Low Date04/27/23

Key Stats

  • Market Cap3.341M
  • Shares Out18.93M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.97
  • YTD % Change-34.91

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.1765
  • 52 Week High3.29
  • 52 Week High Date08/11/22
  • 52 Week Low0.02
  • 52 Week Low Date04/27/23
  • Market Cap3.341M
  • Shares Out18.93M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.97
  • YTD % Change-34.91

RATIOS/PROFITABILITY

  • EPS (TTM)-13.34
  • P/E (TTM)-0.01
  • Fwd P/E (NTM)-0.08
  • EBITDA (TTM)-72.743M
  • ROE (TTM)-6,232.76%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-127.11%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Evelo Biosciences Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Evelo Biosciences, Inc. is a clinical-stage biotechnology company. The Company is focused on discovering and developing a class of oral medicines that act on immune cells in the small intestine with systemic effects. It has built a platform to discover and develop oral medicines, which target the small intestinal axis (SINTAX). Its product candidates are pharmaceutical preparations of single strains of microbes or their extracellular vesicles (EVs). Its product candidate...
Craig Jalbert
President, Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer, Company Secretary, Director
Daniel Char J.D.
General Counsel, Secretary
Address
124 WASHINGTON STREET, SUITE 101
Foxboro, MA
02035
United States

Top Peers

SYMBOLLASTCHG%CHG
ALLR
Allarity Therapeutics Inc
0.6649-0.0079-1.1742%
BBLG
Bone Biologics Corp
1.91-0.29-13.18%
CFRXQ
ContraFect Corp
0.015UNCHUNCH
CALA
BNTC
Benitec Biopharma Inc
9.55+0.08+0.84%